SHOTS -NPR's Health Blog
CDC - Centers for Disease Control and Prevention
-----------------------------
NY Organ Donor Network
Making Health Care Safer
Smoking causes immediate damage
Get Smart for Healthcare
Centers for Disease Control and Prevention (CDC)

eHealth Topics

Donate Life America

Bertalan Mesko,MD,PhD
Editor-in-Chief

CDC.gov
CDC.gov

Alzheimer's Disease Education & Referral Center

Colorectal Cancer Screen
Adult Smoking
CDC.gov
Child Safety Network

Healthy Environment,Healthy Kids

NRC Widget

Antiplatelet therapy:Comparison of prasugrel and clopidogrel in the setting of ACS without revascularization

Nature Reviews Cardiology 9,611 (2012).
doi:10.1038/nrcardio.2012.133

Author:Bryony M. Mearns

In patients with acute coronary syndrome (ACS) who have not undergone revascularization,but are receiving aspirin,prasugrel is associated with a similar rate of major cardiovascular events and has a similar safety profile as clopidogrel when used over the long term (∼15 months). These ‘neutral’


Nature Reviews Cardiology –Issue –nature.com science feeds

Be Sociable,Share!

Leave a Reply

  

  

  

You can use these HTML tags

<a href=""title=""><abbr title=""><acronym title=""><b><blockquote cite=""><cite><code><del datetime=""><em><i><q cite=""><strike><strong>